Rocket Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Rocket Pharmaceuticals generated cash of -$194,916,000, which is less than the previous year. Cash used in financing activities reached the amount of $208,401,000 last year. Net change in cash is therefore -$84,581,000.
Cash Flow
| 2014 | -9.74M | 0 | 568K |
|---|---|---|---|
| 2015 | -17.41M | -31.67M | 125.51M |
| 2016 | -37.26M | -66.05M | 16 |
| 2017 | -26.11M | 75.01M | 25.40K |
| 2018 | -53.78M | -5.27M | 153.50M |
| 2019 | -64.66M | -39.01M | 177.79M |
| 2020 | -74.64M | -96.59M | 282.98M |
| 2021 | -121.16M | 18.85M | 37.68K |
| 2022 | -178.14M | -69.32M | 155.28M |
| 2023 | -194.91M | -98.06M | 208.40M |
RCKT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 141.85M | 234.03M | 298.66M | 186.90M | 112.79M | 18.34M | 29.79M | 80.04M | 3.61M | 12.79M |
Operating activities | ||||||||||
Net income | -245.59M | -221.86M | -169.06M | -139.7M | -77.27M | -74.51M | -29.49M | -42.85M | -67.98M | -9.53M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 7.09M | 6.26M | 5.37M | 1.14M | 426K | 330K | 200K | 169K | 45K | 0 |
Stock-based compensation expense | 39.40M | 31.00M | 29.23M | 18.56M | 13.37M | 0 | 4.03M | 2.90M | 2.38M | 177K |
| Deferred income tax benefit | 39.40M | 31.00M | 29.23M | 18.56M | 13.37M | 0 | 4.03M | 2.90M | 2.38M | 177K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 9.67M | -4.82M | 11.01M | -2.72M | 5.89M | -1.14M | -41K | 487K | 917K |
Cash generated by operating activities | -194.91M | -178.14M | -121.16M | -74.64M | -64.66M | -53.78M | -26.11M | -37.26M | -17.41M | -9.74M |
Investing activities | ||||||||||
Purchases Of Investments | -390.92M | -376.32M | -245.87M | -209.34M | -184.29M | -141.08M | -27.20M | -122.27M | -33.69M | 0 |
Investments In Property Plant And Equipment | -16.47M | -8.61M | -7.71M | -29.05M | -23.26M | -1.45M | -70K | -487K | -412K | 0 |
Acquisitions Net | 0 | 42.72M | 95K | 8.45M | 15.74K | 76.34M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -98.06M | -69.32M | 18.85M | -96.59M | -39.01M | -5.27M | 75.01M | -66.05M | -31.67M | 0 |
Financing activities | ||||||||||
Common Stock Issued | 208.39M | 155.33M | 37.68M | 281.35M | 178.10M | 154.02M | 35K | 0 | 112.05M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -47K | 0 | -72K | 0 | -668K | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -201K | -5.55M | 0 | 0 | 0 | 0 | 13.35M | -1.41M |
Cash used in financing activities | 208.40M | 155.28M | 37.68K | 282.98M | 177.79M | 153.50M | 25.40K | 16 | 125.51M | 568K |
Net Change In Cash | -84.58M | -92.18M | -64.62M | 111.75M | 74.11M | 94.44M | 48.92M | -50.24M | 76.42M | -9.17M |
Cash at end of period | 57.27M | 141.85M | 234.03M | 298.66M | 186.90M | 112.79M | 78.72M | 29.79M | 80.04M | 3.61M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |